How shady sites use a loophole to sell Americans dangerous GLP-1 copycat formulas
gomodernhealth.com
LaunchIndex first observed How shady sites use a loophole to sell Americans dangerous GLP-1 copycat formulas (gomodernhealth.com) live on 9 November 2026. View its launch screenshot, category, and verification evidence.

A launch record built from evidence.
How shady sites use a loophole to sell Americans dangerous GLP-1 copycat formulas (gomodernhealth.com) was first observed live on 9 November 2026.
A health article explaining how some sites disguise GLP-1 copycat drugs, warn about FDA actions, and compare counterfeit products with legal prescriptions.
Its profile is classified as Media within Health / Health and wellness.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- gomodernhealth.com
- Category
- Health / Health and wellness
- Website type
- Media
- Observed title
- How shady sites use a loophole to sell Americans dangerous GLP-1 copycat formulas
- Observed description
- They call it 'GLP-1 S' instead of semaglutide, stamp 'for research use only' on the vial, and sell the mixing water in the same cart. The FDA has now put the trick in writing. The three kinds of GLP-1 copy on the market, which one is legal, and how to tell them apart before you pay.
- Detected technologies
- None detected
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 90%
- HTTP status
- 200
A canonical launch profile for gomodernhealth.com.
Share the profile directly or add the optional badge to the website. A badge is never required for inclusion, verification, or ranking.
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.